Company · CIK 0001759425 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Mirum Pharmaceuticals, Inc. · MIRM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 SForm 4 → | Sep 15, 4:10 pm EDT | Eric BjerkholtCHIEF FINANCIAL OFFICER | 9,943 | $98.37 | $978,093 | 44,745 | −18.2% | |
| Sep 11, 2026 MForm 4 → | Sep 15, 4:10 pm EDT | Eric BjerkholtCHIEF FINANCIAL OFFICER | 18,333 | — | — | 54,688 | — | |
| Sep 2, 2026 SForm 4 → | Sep 3, 6:54 pm EDT | Jolanda HoweSVP, GLOBAL CONTROLLER | 658 | $100.00 | $65,800 | 616 | −51.6% | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 3, 6:52 pm EDT | Christopher PeetzCHIEF EXECUTIVE OFFICER, Director | 30,000 | $98.68 | $2,960,401 | 194,440 | −13.4% | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 3, 6:52 pm EDT | Christopher PeetzCHIEF EXECUTIVE OFFICER, Director | 30,000 | $2.94 | $88,080 | 224,440 | — | 10b5-1 |
| Aug 18, 2026 SForm 4 → | Aug 19, 6:19 pm EDT | Jolanda HoweSVP, GLOBAL CONTROLLER | 40,000 | $100.00 | $4,000,000 | 1,274 | −96.9% | |
| Aug 18, 2026 MForm 4 → | Aug 19, 6:19 pm EDT | Jolanda HoweSVP, GLOBAL CONTROLLER | 40,000 | $6.27 | $250,800 | 41,274 | — | |
| Aug 11, 2026 SForm 4 → | Aug 12, 5:14 pm EDT | Eric BjerkholtCHIEF FINANCIAL OFFICER | 6,001 | $99.90 | $599,510 | 36,355 | −14.2% | 10b5-1 |
| Aug 10, 2026 SForm 4 → | Aug 11, 5:41 pm EDT | Christopher PeetzCHIEF EXECUTIVE OFFICER, Director | 20,000 | $98.92 | $1,978,402 | 194,309 | −9.33% | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 11, 5:41 pm EDT | Christopher PeetzCHIEF EXECUTIVE OFFICER, Director | 20,000 | $2.94 | $58,720 | 214,309 | — | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 5, 4:26 pm EDT | Jolanda HoweSVP, GLOBAL CONTROLLER | 1,840 | $105.29 | $193,734 | 1,274 | −59.1% | 10b5-1 |
| Jul 6, 2026 SForm 4 → | Jul 8, 5:12 pm EDT | Christopher PeetzCHIEF EXECUTIVE OFFICER, Director | 20,000 | $122.27 | $2,445,382 | 194,309 | −9.33% | 10b5-1 |
| Jul 6, 2026 MForm 4 → | Jul 8, 5:12 pm EDT | Christopher PeetzCHIEF EXECUTIVE OFFICER, Director | 20,000 | $2.94 | $58,720 | 214,309 | — | 10b5-1 |
| Jul 6, 2026 SForm 4 → | Jul 8, 5:07 pm EDT | Eric BjerkholtCHIEF FINANCIAL OFFICER | 5,000 | $122.25 | $611,273 | 42,181 | −10.6% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 2, 6:01 pm EDT | Jolanda HoweSVP, GLOBAL CONTROLLER | 2,721 | $120.00 | $326,520 | 3,114 | −46.6% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 MForm 4 → | Sep 15, 4:10 pm EDT | Eric BjerkholtCHIEF FINANCIAL OFFICER | 18,333 | — | — | 0 | — | |
| Sep 1, 2026 MForm 4 → | Sep 3, 6:52 pm EDT | Christopher PeetzCHIEF EXECUTIVE OFFICER, Director | 30,000 | — | — | 58,487 | — | 10b5-1 |
| Aug 18, 2026 MForm 4 → | Aug 19, 6:19 pm EDT | Jolanda HoweSVP, GLOBAL CONTROLLER | 40,000 | — | — | 0 | — | |
| Aug 10, 2026 MForm 4 → | Aug 11, 5:41 pm EDT | Christopher PeetzCHIEF EXECUTIVE OFFICER, Director | 20,000 | — | — | 88,487 | — | 10b5-1 |
| Jul 6, 2026 MForm 4 → | Jul 8, 5:12 pm EDT | Christopher PeetzCHIEF EXECUTIVE OFFICER, Director | 20,000 | — | — | 108,487 | — | 10b5-1 |